{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:11:33Z","timestamp":1776784293436,"version":"3.51.2"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R21AR072283"],"award-info":[{"award-number":["R21AR072283"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["UH3TR002142"],"award-info":[{"award-number":["UH3TR002142"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-07970-8","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:58:17Z","timestamp":1744163897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differential response of tissue engineered skeletal muscle from rheumatoid arthritis patients and healthy controls"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3040-1326","authenticated-orcid":false,"given":"Catherine E.","family":"Oliver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0191-9882","authenticated-orcid":false,"given":"Jonathan L.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3452-8607","authenticated-orcid":false,"given":"James S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1930-9684","authenticated-orcid":false,"given":"William E.","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim M.","family":"Huffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-4489","authenticated-orcid":false,"given":"George A.","family":"Truskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"7970_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3899\/jrheum.110901","volume":"88","author":"P. Jacobs","year":"2011","unstructured":"Jacobs, P., Bissonnette, R. & Guenther, L. C. Socioeconomic burden of immune-mediated inflammatory diseases\u2014focusing on work productivity and disability. J. Rheumatol. Suppl. 88, 55\u201361 (2011).","journal-title":"J. Rheumatol. Suppl."},{"key":"7970_CR2","doi-asserted-by":"publisher","first-page":"v3","DOI":"10.1093\/rheumatology\/kes113","volume":"51","author":"E. Choy","year":"2012","unstructured":"Choy, E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology 51, v3\u2013v11 (2012).","journal-title":"Rheumatology"},{"key":"7970_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"D. L. Scott","year":"2010","unstructured":"Scott, D. L., Wolfe, F. & Huizinga, T. W. Rheumatoid arthritis. Lancet 376, 1094\u20131108 (2010).","journal-title":"Lancet"},{"key":"7970_CR4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/rheumatology\/kex020","volume":"56","author":"J. F. Baker","year":"2017","unstructured":"Baker, J. F. et al. Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis. Rheumatology56, 981\u2013988 (2017).","journal-title":"Rheumatology"},{"key":"7970_CR5","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10067-014-2730-z","volume":"33","author":"L. A. Aguila","year":"2014","unstructured":"Aguila, L. A. et al. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis. Clin. Rheumatol. 33, 1093\u20131098 (2014).","journal-title":"Clin. Rheumatol."},{"key":"7970_CR6","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1002\/art.34464","volume":"64","author":"H. R. Kramer","year":"2012","unstructured":"Kramer, H. R., Fontaine, K. R., Bathon, J. M. & Giles, J. T. Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes. Arthritis Rheum. 64, 2438\u20132450 (2012).","journal-title":"Arthritis Rheum."},{"key":"7970_CR7","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/rheumatology\/kew243","volume":"55","author":"A. B. Lemmey","year":"2016","unstructured":"Lemmey, A. B. et al. Tight control of disease activity fails to improve body composition or physical function in rheumatoid arthritis patients. Rheumatology 55, 1736\u20131745 (2016).","journal-title":"Rheumatology"},{"key":"7970_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1749-6632.2000.tb06515.x","volume":"904","author":"R. Roubenoff","year":"2000","unstructured":"Roubenoff, R. Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann. N.Y. Acad. Sci. 904, 553\u2013557 (2000).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"7970_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/ar2658","volume":"11","author":"R. Roubenoff","year":"2009","unstructured":"Roubenoff, R. Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century. Arthritis Res. Ther. 11, 108 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"7970_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/art.23719","volume":"59","author":"J. T. Giles","year":"2008","unstructured":"Giles, J. T. et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum. 59, 807\u2013815 (2008).","journal-title":"Arthritis Rheum."},{"key":"7970_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard.2004.034769","volume":"65","author":"A. Hakkinen","year":"2006","unstructured":"Hakkinen, A. et al. Muscle strength, pain, and disease activity explain individual subdimensions of the Health Assessment Questionnaire disability index, especially in women with rheumatoid arthritis. Ann. Rheum. Dis. 65, 30\u201334 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"7970_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/ard.51.1.35","volume":"51","author":"C. Ekdahl","year":"1992","unstructured":"Ekdahl, C. & Broman, G. Muscle strength, endurance, and aerobic capacity in rheumatoid arthritis: a comparative study with healthy subjects. Ann. Rheum. Dis. 51, 35\u201340 (1992).","journal-title":"Ann. Rheum. Dis."},{"key":"7970_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/art.1780390707","volume":"39","author":"L. C. Rall","year":"1996","unstructured":"Rall, L. C. et al. Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor alpha. Arthritis Rheum. 39, 1115\u20131124 (1996).","journal-title":"Arthritis Rheum."},{"key":"7970_CR14","doi-asserted-by":"publisher","unstructured":"Huffman, K. M. et al. Molecular alterations in skeletal muscle in rheumatoid arthritis are related to disease activity, physical inactivity, and disability. Arthritis Res. Therapy 19, https:\/\/doi.org\/10.1186\/s13075-016-1215-7 (2017).","DOI":"10.1186\/s13075-016-1215-7"},{"key":"7970_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/698313","volume":"2014","author":"Y. Yoshida","year":"2014","unstructured":"Yoshida, Y. & Tanaka, T. Interleukin 6 and rheumatoid arthritis. Biomed. Res. Int. 2014, 698313 (2014).","journal-title":"Biomed. Res. Int."},{"key":"7970_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/conmed-2018-000005","volume":"2","author":"S. A. Jones","year":"2018","unstructured":"Jones, S. A. et al. Interleukin 6: the biology behind the therapy. Consid. Med. 2, 2\u20136 (2018).","journal-title":"Consid. Med."},{"key":"7970_CR17","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1111\/febs.12338","volume":"280","author":"P. Munoz-Canoves","year":"2013","unstructured":"Munoz-Canoves, P., Scheele, C., Pedersen, B. K. & Serrano, A. L. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?. FEBS J. 280, 4131\u20134148 (2013).","journal-title":"FEBS J."},{"key":"7970_CR18","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","volume":"20","author":"F. J. Barrat","year":"2019","unstructured":"Barrat, F. J., Crow, M. K. & Ivashkiv, L. B. Interferon target-gene expression and epigenomic signatures in health and disease. Nat. Immunol. 20, 1574\u20131583 (2019).","journal-title":"Nat. Immunol."},{"key":"7970_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/pr.57.2.3","volume":"57","author":"B. N. Cronstein","year":"2005","unstructured":"Cronstein, B. N. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol. Rev. 57, 163\u2013172 (2005).","journal-title":"Pharmacol. Rev."},{"key":"7970_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"B. N. Cronstein","year":"2020","unstructured":"Cronstein, B. N. & Aune, T. M. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat. Rev. Rheumatol. 16, 145\u2013154 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"7970_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12929-021-00714-w","volume":"28","author":"T. Ollewagen","year":"2021","unstructured":"Ollewagen, T., Myburgh, K. H., van de Vyver, M. & Smith, C. Rheumatoid cachexia: the underappreciated role of myoblast, macrophage and fibroblast interplay in the skeletal muscle niche. J. Biomed. Sci. 28, 15 (2021).","journal-title":"J. Biomed. Sci."},{"key":"7970_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2147\/JIR.S219586","volume":"13","author":"R. Harrington","year":"2020","unstructured":"Harrington, R., Al Nokhatha, S. A. & Conway, R. J. A. K. Inhibitors in rheumatoid arthritis: an evidence-based review on the emerging clinical data. J. Inflamm. Res. 13, 519\u2013531 (2020).","journal-title":"J. Inflamm. Res."},{"key":"7970_CR23","doi-asserted-by":"publisher","unstructured":"Madden, L., Juhas, M., Kraus, W. E., Truskey, G. A. & Bursac, N. Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs. eLife 4, https:\/\/doi.org\/10.7554\/eLife.04885 (2015).","DOI":"10.7554\/eLife.04885"},{"key":"7970_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/term.3266","volume":"16","author":"C. E. Oliver","year":"2022","unstructured":"Oliver, C. E. et al. Tissue engineered skeletal muscle model of rheumatoid arthritis using human primary skeletal muscle cells. J. Tissue Eng. Regen. Med. 16, 128\u2013139 (2022).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"7970_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/ten.tea.2015.0359","volume":"22","author":"C. S. Cheng","year":"2016","unstructured":"Cheng, C. S., Ran, L., Bursac, N., Kraus, W. E. & Truskey, G. A. Cell density and joint microRNA-133a and microRNA-696 inhibition enhance differentiation and contractile function of engineered human skeletal muscle tissues. Tissue Eng. Part A 22, 573\u2013583 (2016).","journal-title":"Tissue Eng. Part A"},{"key":"7970_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.biomaterials.2018.08.058","volume":"198","author":"A. Khodabukus","year":"2019","unstructured":"Khodabukus, A. et al. Electrical stimulation increases hypertrophy and metabolic flux in tissue-engineered human skeletal muscle. Biomaterials 198, 259\u2013269 (2019).","journal-title":"Biomaterials"},{"key":"7970_CR27","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1056\/NEJMoa1112168","volume":"367","author":"W. J. Sandborn","year":"2012","unstructured":"Sandborn, W. J. et al. Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. N. Engl. J. Med. 367, 616\u2013624 (2012).","journal-title":"N. Engl. J. Med."},{"key":"7970_CR28","doi-asserted-by":"publisher","unstructured":"Chen, Z., Li, B., Zhan, R. Z., Rao, L. & Bursac, N. Exercise mimetics and JAK inhibition attenuate IFN-gamma-induced wasting in engineered human skeletal muscle. Sci. Adv. 7, https:\/\/doi.org\/10.1126\/sciadv.abd9502 (2021).","DOI":"10.1126\/sciadv.abd9502"},{"key":"7970_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2165\/00003088-199630030-00002","volume":"30","author":"B. Bannwarth","year":"1996","unstructured":"Bannwarth, B., Pehourcq, F., Schaeverbeke, T. & Dehais, J. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clin. Pharmacokinet. 30, 194\u2013210 (1996).","journal-title":"Clin. Pharmacokinet."},{"key":"7970_CR30","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/bcp.14057","volume":"85","author":"C. J. Lucas","year":"2019","unstructured":"Lucas, C. J., Dimmitt, S. B. & Martin, J. H. Optimising low-dose methotrexate for rheumatoid arthritis-A review. Br. J. Clin. Pharmacol. 85, 2228\u20132234 (2019).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"7970_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.641734","volume":"8","author":"P. Villar-Fincheira","year":"2021","unstructured":"Villar-Fincheira, P. et al. Role of interleukin-6 in vascular health and disease. Front. Mol. Biosci. 8, 641734 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"7970_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.684899","volume":"12","author":"T. Pircher","year":"2021","unstructured":"Pircher, T. et al. Hypoxic signaling in skeletal muscle maintenance and regeneration: a systematic review. Front. Physiol. 12, (2021). 684899.","journal-title":"Front. Physiol."},{"key":"7970_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12929-016-0281-0","volume":"23","author":"C. M. Quinonez-Flores","year":"2016","unstructured":"Quinonez-Flores, C. M., Gonzalez-Chavez, S. A. & Pacheco-Tena, C. Hypoxia and its implications in rheumatoid arthritis. J. Biomed. Sci. 23, 62 (2016).","journal-title":"J. Biomed. Sci."},{"key":"7970_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.18632\/oncoscience.458","volume":"5","author":"S. S. Chauhan","year":"2018","unstructured":"Chauhan, S. S. & Warfel, N. A. Targeting PIM kinases to oppose hypoxia-mediated therapeutic resistance. Oncoscience 5, 254\u2013255 (2018).","journal-title":"Oncoscience"},{"key":"7970_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1993-3","volume":"10","author":"Y. Liu","year":"2019","unstructured":"Liu, Y. et al. Pim1 kinase positively regulates myoblast behaviors and skeletal muscle regeneration. Cell Death Dis. 10, 773 (2019).","journal-title":"Cell Death Dis."},{"key":"7970_CR36","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/molehr\/gax013","volume":"23","author":"R. Lim","year":"2017","unstructured":"Lim, R., Barker, G. & Lappas, M. Inhibition of PIM1 kinase attenuates inflammation-induced pro-labour mediators in human foetal membranes in vitro. Mol. Hum. Reprod. 23, 428\u2013440 (2017).","journal-title":"Mol. Hum. Reprod."},{"key":"7970_CR37","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3892\/mmr.2014.2139","volume":"9","author":"C. Liang","year":"2014","unstructured":"Liang, C. & Li, Y. Y. Use of regulators and inhibitors of Pim-1, a serine\/threonine kinase, for tumour therapy (review). Mol. Med. Rep. 9, 2051\u20132060 (2014).","journal-title":"Mol. Med. Rep."},{"key":"7970_CR38","doi-asserted-by":"publisher","unstructured":"Gallot, Y. S. & Bohnert, K. R. Confounding roles of ER stress and the unfolded protein response in skeletal muscle atrophy. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22052567 (2021).","DOI":"10.3390\/ijms22052567"},{"key":"7970_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/febs.14358","volume":"286","author":"D. Afroze","year":"2019","unstructured":"Afroze, D. & Kumar, A. ER stress in skeletal muscle remodeling and myopathies. FEBS J. 286, 379\u2013398 (2019).","journal-title":"FEBS J."},{"key":"7970_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/jcp.25852","volume":"233","author":"K. R. Bohnert","year":"2018","unstructured":"Bohnert, K. R., McMillan, J. D. & Kumar, A. Emerging roles of ER stress and unfolded protein response pathways in skeletal muscle health and disease. J. Cell Physiol. 233, 67\u201378 (2018).","journal-title":"J. Cell Physiol."},{"key":"7970_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6949347","volume":"2019","author":"T. Poplawski","year":"2019","unstructured":"Poplawski, T., Pytel, D., Dziadek, J. & Majsterek, I. Interplay between redox signaling, oxidative stress, and unfolded protein response (UPR) in pathogenesis of human diseases. Oxid. Med. Cell Longev. 2019, 6949347 (2019).","journal-title":"Oxid. Med. Cell Longev."},{"key":"7970_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5617431","volume":"2019","author":"Y. Li","year":"2019","unstructured":"Li, Y. et al. Changes in serum cytokines may predict therapeutic efficacy of tofacitinib in rheumatoid arthritis. Mediators Inflamm. 2019, 5617431 (2019).","journal-title":"Mediators Inflamm."},{"key":"7970_CR43","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/jisp.jisp_362_17","volume":"22","author":"S. Thilagar","year":"2018","unstructured":"Thilagar, S. et al. Comparison of serum tumor necrosis factor-alpha levels in rheumatoid arthritis individuals with and without chronic periodontitis: a biochemical study. J. Indian Soc. Periodontol. 22, 116\u2013121 (2018).","journal-title":"J. Indian Soc. Periodontol."},{"key":"7970_CR44","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/rr67","volume":"2","author":"M. B. Reid","year":"2001","unstructured":"Reid, M. B. & Li, Y. -P. Tumor necrosis factor-\u03b1 and muscle wasting: a cellular perspective. Respir. Res. 2, 269\u2013272 (2001).","journal-title":"Respir. Res."},{"key":"7970_CR45","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/00002281-200111000-00005","volume":"13","author":"Y. P. Li","year":"2001","unstructured":"Li, Y. P. & Reid, M. B. Effect of tumor necrosis factor-alpha on skeletal muscle metabolism. Curr. Opin. Rheumatol. 13, 483\u2013487 (2001).","journal-title":"Curr. Opin. Rheumatol."},{"key":"7970_CR46","first-page":"871","volume":"12","author":"Y. P. Li","year":"1998","unstructured":"Li, Y. P., Schwartz, R. J., Waddell, I. D., Holloway, B. R. & Reid, M. B. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J. 12, 871\u2013880 (1998).","journal-title":"FASEB J."},{"key":"7970_CR47","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1161\/01.CIR.102.14.1690","volume":"102","author":"X. Li","year":"2000","unstructured":"Li, X. et al. Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 102, 1690\u20131696 (2000).","journal-title":"Circulation"},{"key":"7970_CR48","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1152\/japplphysiol.00898.2007","volume":"104","author":"B. J. Hardin","year":"2008","unstructured":"Hardin, B. J. et al. TNF-alpha acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle. J. Appl. Physiol.104, 694\u2013699 (2008).","journal-title":"J. Appl. Physiol."},{"key":"7970_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1096\/fj.03-0251com","volume":"18","author":"R. C. Langen","year":"2004","unstructured":"Langen, R. C. et al. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization. FASEB J. 18, 227\u2013237 (2004).","journal-title":"FASEB J."},{"key":"7970_CR50","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","volume":"289","author":"D. C. Guttridge","year":"2000","unstructured":"Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C. Y. & Baldwin, A. S. Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289, 2363\u20132366 (2000).","journal-title":"Science"},{"key":"7970_CR51","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/mus.20635","volume":"35","author":"L. N. van Kann","year":"2007","unstructured":"van Kann, L. N. & Bakker, A. J. Effect of tumor necrosis factor alpha on electrically induced calcium transients elicited in C2C12 skeletal myotubes. Muscle Nerve 35, 251\u2013253 (2007).","journal-title":"Muscle Nerve"},{"key":"7970_CR52","doi-asserted-by":"publisher","first-page":"R698","DOI":"10.1152\/ajpregu.00039.2002","volume":"283","author":"R. A. Frost","year":"2002","unstructured":"Frost, R. A., Nystrom, G. J. & Lang, C. H. Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R698\u2013R709 (2002).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"7970_CR53","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1113\/jphysiol.2010.203356","volume":"589","author":"M. B. Reid","year":"2011","unstructured":"Reid, M. B. & Moylan, J. S. Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease. J. Physiol. 589, 2171\u20132179 (2011).","journal-title":"J. Physiol."},{"key":"7970_CR54","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1152\/physrev.00061.2017","volume":"99","author":"L. Larsson","year":"2019","unstructured":"Larsson, L. et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol. Rev. 99, 427\u2013511 (2019).","journal-title":"Physiol. Rev."},{"key":"7970_CR55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12877-018-1007-9","volume":"18","author":"Y. D. Rong","year":"2018","unstructured":"Rong, Y. D., Bian, A. L., Hu, H. Y., Ma, Y. & Zhou, X. Z. Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10. BMC Geriatr. 18, 308 (2018).","journal-title":"BMC Geriatr."},{"key":"7970_CR56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.14283\/jfa.2017.33","volume":"7","author":"L. A. Consitt","year":"2018","unstructured":"Consitt, L. A. & Clark, B. C. The vicious cycle of myostatin signaling in sarcopenic obesity: myostatin role in skeletal muscle growth, insulin signaling and implications for clinical trials. J. Frailty Aging 7, 21\u201327 (2018).","journal-title":"J. Frailty Aging"},{"key":"7970_CR57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/crt2.43","volume":"6","author":"A. S. Ryan","year":"2021","unstructured":"Ryan, A. S. & Li, G. Skeletal muscle myostatin gene expression and sarcopenia in overweight and obese middle-aged and older adults. JCSM Clin. Rep. 6, 137\u2013142 (2021).","journal-title":"JCSM Clin. Rep."},{"key":"7970_CR58","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000356740","volume":"60","author":"T. A. White","year":"2014","unstructured":"White, T. A. & LeBrasseur, N. K. Myostatin and sarcopenia: opportunities and challenges - a mini-review. Gerontology 60, 289\u2013293 (2014).","journal-title":"Gerontology"},{"key":"7970_CR59","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4235\/agmr.19.0028","volume":"23","author":"J. Y. Kwak","year":"2019","unstructured":"Kwak, J. Y. & Kwon, K. S. Pharmacological interventions for treatment of sarcopenia: current status of drug development for sarcopenia. Ann. Geriatr. Med. Res. 23, 98\u2013104 (2019).","journal-title":"Ann. Geriatr. Med. Res."},{"key":"7970_CR60","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"I. B. McInnes","year":"2011","unstructured":"McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205\u20132219 (2011).","journal-title":"N. Engl. J. Med."},{"key":"7970_CR61","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00393-018-0584-5","volume":"78","author":"K. Kruger","year":"2019","unstructured":"Kruger, K. & Nusslein, H. Cardiovascular comorbidities in rheumatoid arthritis]. Z. Rheumatol. 78, 221\u2013227 (2019).","journal-title":"Z. Rheumatol."},{"key":"7970_CR62","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D. Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against rheumatism collaborative initiative. Arthritis Rheum. 62, 2569\u20132581 (2010).","journal-title":"Arthritis Rheum."},{"key":"7970_CR63","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"M. L. Prevoo","year":"1995","unstructured":"Prevoo, M. L. et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 38, 44\u201348 (1995).","journal-title":"Arthritis Rheum."},{"key":"7970_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M. Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10\u201312 (2011).","journal-title":"EMBnet. J."},{"key":"7970_CR65","doi-asserted-by":"publisher","first-page":"D91","DOI":"10.1093\/nar\/gkr895","volume":"40","author":"P. J. Kersey","year":"2012","unstructured":"Kersey, P. J. et al. Ensembl Genomes: an integrative resource for genome-scale data from non-vertebrate species. Nucleic Acids Res. 40, D91\u2013D97 (2012).","journal-title":"Nucleic Acids Res."},{"key":"7970_CR66","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S. Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2014a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"7970_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"M. I. Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"7970_CR68","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","volume":"12","author":"W. Huber","year":"2015","unstructured":"Huber, W. et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat. Methods 12, 115\u2013121 (2015).","journal-title":"Nat. Methods"},{"key":"7970_CR69","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"V. K. Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"7970_CR70","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A. Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"updated-by":[{"DOI":"10.1038\/s42003-025-08286-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000}}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07970-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T07:03:46Z","timestamp":1748675026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-07970-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7970"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-07970-8","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"17 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s42003-025-08286-3","URL":"https:\/\/doi.org\/10.1038\/s42003-025-08286-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study complied with the Helsinki Declaration and was approved by the Duke University Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"583"}}